Title
Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis
Date Issued
01 March 2009
Access level
open access
Resource Type
journal article
Author(s)
Publisher(s)
Elsevier
Abstract
Resistance of Mycobacterium tuberculosis to pyrazinamide is associated with mutations in the pncA gene, which codes for pyrazinamidase. The association between the enzymatic activity of mutated pyrazinamidases and the level of pyrazinamide resistance remains poorly understood. Twelve M. tuberculosis clinical isolates resistant to pyrazinamide were selected based on Wayne activity and localization of pyrazinamidase mutation. Recombinant pyrazinamidases were expressed and tested for their kinetic parameters (activity, kcat, Km, and efficiency). Pyrazinamide resistance level was measured by Bactec-460TB and 7H9 culture. The linear correlation between the resistance level and the kinetic parameters of the corresponding mutated pyrazinamidase was calculated. The enzymatic activity and efficiency of the mutated pyrazinamidases varied with the site of mutation and ranged widely from low to high levels close to the corresponding of the wild type enzyme. The level of resistance was significantly associated with pyrazinamidase activity and efficiency, but only 27.3% of its statistical variability was explained. Although pyrazinamidase mutations are indeed associated with resistance, the loss of pyrazinamidase activity and efficiency as assessed in the recombinant mutated enzymes is not sufficient to explain a high variability of the level of pyrazinamide resistance, suggesting that complementary mechanisms for pyrazinamide resistance in M. tuberculosis with mutations in pncA are more important than currently thought. © 2009 Elsevier Ltd. All rights reserved.
Start page
109
End page
113
Volume
89
Issue
2
Language
English
OCDE Knowledge area
Sistema respiratorio
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-61649111323
PubMed ID
Source
Tuberculosis
ISSN of the container
14729792
Sponsor(s)
We acknowledge Drs. Mark A. Swancutt, Carlton Evans, David Moore, Alberto Mendoza, Laurie Baumann and Marjory Bravard for their advice and review of the manuscript. The National Institute of Allergy and Infectious Diseases, National Institutes of Health US, funded this research under the terms of Award No # 1 R03 AI067608-0. P. Sheen and M.J. Zimic received some support from TMRC New Tools to Understand and Control Endemic Parasites # 1 P01 AI51976. J. López-Llano received an award from the MAE-AECI fellowship (Spain). Funding: The National Institute of Allergy and Infectious Diseases, National Institutes of Health US, funded this research. Competing interests: None declared. Ethical approval: Not required.
Sources of information:
Directorio de Producción Científica
Scopus